131 related articles for article (PubMed ID: 17172733)
1. The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation.
Skovseth DK; Küchler AM; Haraldsen G
Methods Mol Biol; 2007; 360():253-68. PubMed ID: 17172733
[TBL] [Abstract][Full Text] [Related]
2. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
[TBL] [Abstract][Full Text] [Related]
3. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
[TBL] [Abstract][Full Text] [Related]
5. A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line.
Aranda E; Owen GI
Biol Res; 2009; 42(3):377-89. PubMed ID: 19915746
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin.
Thaloor D; Singh AK; Sidhu GS; Prasad PV; Kleinman HK; Maheshwari RK
Cell Growth Differ; 1998 Apr; 9(4):305-12. PubMed ID: 9563850
[TBL] [Abstract][Full Text] [Related]
7. Identification of HIV-1 Tat peptides for future therapeutic angiogenesis.
Ismail M; Henklein P; Huang X; Braumann C; Rückert RI; Dubiel W
Eur J Haematol; 2006 Aug; 77(2):157-65. PubMed ID: 16800839
[TBL] [Abstract][Full Text] [Related]
8. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
9. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay.
Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI
Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400
[TBL] [Abstract][Full Text] [Related]
10. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
11. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
Chai J; Jones MK; Tarnawski AS
FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
[TBL] [Abstract][Full Text] [Related]
12. Models of in vitro angiogenesis: endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent.
Zimrin AB; Villeponteau B; Maciag T
Biochem Biophys Res Commun; 1995 Aug; 213(2):630-8. PubMed ID: 7544124
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
14. Novel function of ascorbic acid as an angiostatic factor.
Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
[TBL] [Abstract][Full Text] [Related]
15. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
16. Multiple effects of bevacizumab in angiogenesis: implications for its use in age-related macular degeneration.
Carneiro A; Falcão M; Azevedo I; Falcão Reis F; Soares R
Acta Ophthalmol; 2009 Aug; 87(5):517-23. PubMed ID: 18717653
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of a gradient static magnetic field on normal angiogenesis.
Wang Z; Yang P; Xu H; Qian A; Hu L; Shang P
Bioelectromagnetics; 2009 Sep; 30(6):446-53. PubMed ID: 19405043
[TBL] [Abstract][Full Text] [Related]
18. Evidence of human thrombomodulin domain as a novel angiogenic factor.
Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL
Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324
[TBL] [Abstract][Full Text] [Related]
19. Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8.
Delgado VM; Nugnes LG; Colombo LL; Troncoso MF; Fernández MM; Malchiodi EL; Frahm I; Croci DO; Compagno D; Rabinovich GA; Wolfenstein-Todel C; Elola MT
FASEB J; 2011 Jan; 25(1):242-54. PubMed ID: 20876211
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 does not impair insulin-induced angiogenesis in vitro.
Pellegatta F; Brambilla C; Reduzzi A; Bragheri M; Zerbini G; Catapano AL
Int J Mol Med; 2011 Sep; 28(3):443-8. PubMed ID: 21537834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]